Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia
Open Access
- 12 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (5) , 2256-2262
- https://doi.org/10.1182/blood-2006-07-036657
Abstract
Bone marrow transplantation (BMT) is the only known cure for the hematologic manifestations of Fanconi anemia (FA). Potential benefits of unrelated dKeywords
This publication has 32 references indexed in Scilit:
- The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch RegistryTransplantation and Cellular Therapy, 2006
- Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplantsBlood, 2005
- A 20-year perspective on the International Fanconi Anemia Registry (IFAR)Blood, 2003
- Cancer incidence in persons with Fanconi anemiaBlood, 2003
- Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell graftsBritish Journal of Haematology, 2000
- Bone marrow transplantation in fanconi's anemiaThe International Journal of Cell Cloning, 1996
- Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantationBritish Journal of Haematology, 1983
- Effect of procarbazine and cyclophosphamide on chromosome breakage in Fanconi anemia cells: Relevance to bone marrow transplantationCancer Genetics and Cytogenetics, 1983
- In Vitro Effect of Cyclophosphamide Metabolites on Chromosomes of Fanconi Anaemia PatientsBritish Journal of Haematology, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958